Home » Newsletters » BioWorld Science

BioWorld Science

May 13, 2019

View Archived Issues

Impaired placental function linked to neurodevelopmental disorders

EnGeneIC initiates phase I/IIa study of EDV-based therapeutic in advanced pancreatic cancer

OliX expands ocular disease pipeline with new OLX-304A program in retinitis pigmentosa

FORMA Therapeutics identifies new HDAC6 inhibitors

NIH initiates LATITUDE study to evaluate long-acting HIV medication

Merck & Co. discovers dual TBK1/IKBKE inhibitors

LY-3154207 demonstrates linear plasma PK and promising safety in healthy volunteers

AAI 2019: T-cell therapy could be brought within reach of "virtually all" patients

Investigators present phase II data for CBT-001 for the treatment of pterygia

SHR-1210 plus capecitabine and oxaliplatin shows promising safety and efficacy in GC/GEJ

Gene editing restores skin functionality in blistering disease

Polyphor temporarily halts enrollment in phase III studies of murepavadin

New broad spectrum antivirals discovered at FORGE Life Science

Amgen patents short transient receptor potential channel 6 antagonists

Esteve Pharmaceuticals synthesizes new dual CACNA2D1/NET ligands

Transgene's IND cleared for initiation of phase I study of TG-4050 in ovarian cancer

AVXS-201 gene therapy is effective in reducing symptoms in Rett syndrome murine models

FDA approves Cyramza for hepatocellular carcinoma previously treated with sorafenib

PeptiDream and JCR develop peptides that carry therapeutic payloads across blood-brain barrier

Avotres opens enrollment in phase I/II trial of dendritic cell therapy AVT-001 for type 1 diabetes

First-in-human study evaluates safety, tolerability and pharmacokinetics of GSK-3186899

Data on bispecific fusion protein AG-67650 for wAMD presented

Wuhan Binhui initiates phase I study of OH-2 oncolytic viral therapy in solid tumors

Gene Techno Science and OrthoRebirth collaborate to develop treatment for cleft lip/cleft palate

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...